These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 18258711

  • 1. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
    Kwon HC, Oh SY, Lee S, Kim SH, Han JY, Koh RY, Kim MC, Kim HJ.
    Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y.
    Hepatogastroenterology; 2009 Jan; 56(91-92):908-13. PubMed ID: 19621727
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status.
    Gadducci A, Baicchi U, Marrai R, Facchini V, del Bravo B, Fosella PV, Fioretti P.
    Gynecol Oncol; 1993 Jun; 49(3):354-8. PubMed ID: 8314538
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of coagulation markers in staging of gastric cancer.
    Abbasciano V, Tassinari D, Sartori S, Trevisani L, Arcudi D, Bianchi MP, Liboni A.
    Cancer Detect Prev; 1995 Jun; 19(4):331-6. PubMed ID: 7553675
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S, Wada H, Abe Y, Yamada E, Sakaguchi A, Nishioka J, Hatada T, Ishikura K, Yamada N, Sudo A, Uchida A, Nobori T.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [Abstract] [Full Text] [Related]

  • 11. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
    MacCallum PK, Cooper JA, Martin J, Howarth DJ, Meade TW, Miller GJ.
    Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
    [Abstract] [Full Text] [Related]

  • 12. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M.
    J Surg Oncol; 2007 Feb 01; 95(2):123-8. PubMed ID: 17262742
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N, Tanabe S, Mikami T, Okayasu I, Saigenji K.
    Endoscopy; 2009 May 01; 41(5):427-32. PubMed ID: 19418397
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
    Kunisaki C, Takahashi M, Nagahori Y, Fukushima T, Makino H, Takagawa R, Kosaka T, Ono HA, Akiyama H, Moriwaki Y, Nakano A.
    Endoscopy; 2009 Jun 01; 41(6):498-503. PubMed ID: 19533552
    [Abstract] [Full Text] [Related]

  • 16. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata S, Yamamoto H, Kim BS, Matsuki N, Sawa T, Noh SH, East Asia Surgical Oncology Group.
    Hepatogastroenterology; 2007 Mar 01; 54(74):634-8. PubMed ID: 17523339
    [Abstract] [Full Text] [Related]

  • 17. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer.
    Tomimaru Y, Yano M, Takachi K, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S.
    J Am Coll Surg; 2006 Jan 01; 202(1):139-45. PubMed ID: 16377507
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T.
    Clin Oncol (R Coll Radiol); 2007 Sep 01; 19(7):494-8. PubMed ID: 17513096
    [Abstract] [Full Text] [Related]

  • 20. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
    Gadducci A, Marrai R, Baicchi U, Gagetti O, Facchini V, Genazzani AR.
    Gynecol Oncol; 1996 May 01; 61(2):215-7. PubMed ID: 8626135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.